Copyright (c) 2026 Eminent Biosciences (EMBS)

Permission is hereby granted, free of charge, to any person obtaining a copy
of this software and associated documentation files (the “Software”), to use,
copy, modify, merge, publish, and distribute the Software for academic,
non-commercial, and research purposes, subject to the following conditions:

1. The above copyright notice and this permission notice shall be included in
all copies or substantial portions of the Software.

2. Any publication, presentation, or derivative work using this Software
must cite:

   Nayarisseri et al., “Conformationally informed generative artificial
   intelligence enables discovery of a CDK2-targeting small molecule for
   colorectal cancer”, Nature Communications (submitted).

3. Commercial use, including use in proprietary drug discovery, clinical
development, or product commercialization, is NOT permitted without written
permission from Eminent Biosciences (EMBS).

4. Derivative works must clearly state all modifications and must not use the
name Eminent Biosciences or EMBS to imply endorsement.

THE SOFTWARE IS PROVIDED “AS IS”, WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
SOFTWARE.
